vimarsana.com

StockNews.com began coverage on shares of Pro-Dex (NASDAQ:PDEX – Free Report) in a report issued on Saturday morning. The firm issued a buy rating on the medical instruments supplier’s stock. Pro-Dex Stock Performance Shares of NASDAQ:PDEX opened at $22.50 on Friday. The company has a debt-to-equity ratio of 0.27, a current ratio of 3.79 and […]

Related Keywords

,Dimensional Fund Advisors ,Dex Inc ,Punch Associates Investment Management Inc ,Vanguard Group Inc ,Nasdaq ,Jpmorgan Chase Co ,Dex Company Profile ,Free Report ,Get Free Report ,Associates Investment Management ,Fund Advisors ,Pro Dex Daily ,Pro Dex ,Nasdaq Pdex ,Jpdex ,Medical ,Initiated Coverage ,Stocknews Com ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.